Quest Diagnostics Incorporated
DGX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $21 | $20 | $19 | $17 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $6 | $6 | $7 | $7 |
| Enterprise Value | $27 | $26 | $25 | $23 |
| Revenue | $3 | $3 | $3 | $3 |
| % Growth | 2% | 4.1% | 1.2% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 33.7% | 34.2% | 32.5% | 32.7% |
| EBITDA | $1 | $1 | $0 | $1 |
| % Margin | 19.4% | 21.6% | 18.4% | 19.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 8.7% | 10.2% | 8.3% | 8.5% |
| EPS Diluted | 2.16 | 2.47 | 1.94 | 1.95 |
| % Growth | -12.6% | 27.3% | -0.5% | – |
| Operating Cash Flow | $1 | $1 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |